Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2019

Feb 15, 2019

30198_dirs_2019-02-15_c0baf744-f8f3-40db-8021-a49c6c499b90.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-12-31

Reporting Person: ALTMAN STEVEN R (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-01 Common Stock J 4353 $0.0 Disposed 3449 Direct
2018-08-24 Common Stock J 5000 $0.0 Acquired 5000 Indirect
2018-06-01 Common Stock J 4353 $0.0 Acquired 62855 Indirect
2018-08-24 Common Stock J 5000 $0.0 Disposed 57855 Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units.

F2: Shares were transferred from the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, to ownership under The Lisa and Steve Altman Family Foundation with respect to which the reporting person is an authorized agent.